Hiroyuki Tominaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroyuki Tominaga has a total of 319 co-authors. Here are the top co-authors by number of shared publications:
Ichiro Kawamura
Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
14 shared publications- Gen Inoue
Kitasato University
11 shared publications - Ko Hashimoto
Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan
11 shared publications Setsuro Komiya
Department of Orthopaedic Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
11 shared publications- Shiro Imagama
Department of Orthopedic Surgery and Rheumatology Nagoya University Graduate School of Medicine Nagoya Japan
11 shared publications - Takashi Kaito
Department of Orthopedic Surgery, Osaka Rosai Hospital, Osaka, Japan
11 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (4) , 100884
Inhibition of BMP–Smad1/5 signaling with DMH1 attenuates joint degeneration in a rat model of cuff tear arthropathy
- 6 October 2026
- Published by Elsevier in Osteoarthritis and Cartilage Open
- Vol. 8 (4) , 100884
Open AccessInhibition of BMP–Smad1/5 signaling with DMH1 attenuates joint degeneration in a rat model of cuff tear arthropathy
- Open Access
- 2 October 2026
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 15 (10) , 1183-1195
Anti-RANKL antibody treatment mitigates subchondral bone loss and cartilage degeneration without affecting synovial inflammation in a mouse model of rotator cuff tear arthropathy
Aims: Enhanced osteoclast activity in subchondral bone is implicated in osteoarthritis (OA) progression, but the contribution of osteoclasts versus synovial inflammation in cuff tear arthropathy (CTA) remains unclear. This study investigated whether inhibition of osteoclasts using an anti-receptor activator of nuclear factor κB ligand (RANKL) antibody can suppress joint degeneration in a mouse CTA model without affecting synovial inflammation. Methods: A modified CTA (mCTA) model was established in mice by resecting the supraspinatus and infraspinatus tendons, the superior joint capsule, and the long head of the biceps tendon in the right shoulder of C57BL/6J mice. Mice were assigned to four groups: sham or mCTA, each treated with phosphate-buffered saline or anti-RANKL antibody (5 mg/kg subcutaneously every two weeks). Four weeks post-surgery, histological analyses of the humeral head were performed using the Murine Shoulder Arthritis Score (MSAS), immunohistochemistry for osteoclasts, osteoblasts, RANKL/osteoprotegerin (OPG), inflammatory cytokines, and catabolic enzymes, and quantification of synovial M1 macrophages. Subchondral bone volume (BV) was assessed via the bone volume/tissue volume ratio. Results: The mouse mCTA model reproduced clinically relevant CTA phenotypes, including cartilage degeneration, subchondral bone loss, and joint surface collapse, within four weeks. RANKL expression and osteoclast surface increased in the superior and middle zones, while osteoblasts decreased. Synovial RANKL expression was low and unchanged after mCTA surgery. Anti-RANKL antibody administration significantly suppressed osteoclast surface and preserved subchondral BV, leading to attenuation of cartilage degeneration and reduced expression of inflammatory cytokines and catabolic enzymes in cartilage and subchondral bone. The synovitis score, synovial M1 macrophages, and inflammatory factors were unaffected, indicating that suppression of osteoclasts was sufficient to mitigate joint degeneration. Conclusion: Inhibition of subchondral osteoclasts via anti-RANKL antibody reduces CTA-associated cartilage and bone degeneration without altering synovitis. These findings suggest that targeting osteoclasts may represent a promising disease-modifying strategy for CTA, and targeting RANKL with denosumab may prevent or slow shoulder OA progression. Cite this article: Bone Joint Res 2026;15(10):1183–1195.
- 2 October 2026
- Published by British Editorial Society of Bone & Joint Surgery in Bone & Joint Research
- Vol. 15 (10) , 1183-1195
Open AccessAnti-RANKL antibody treatment mitigates subchondral bone loss and cartilage degeneration without affecting synovial inflammation in a mouse model of rotator cuff tear arthropathy
Aims: Enhanced osteoclast activity in subchondral bone is implicated in osteoarthritis (OA) progression, but the contribution of osteoclasts versus synovial inflammation in cuff tear arthropathy (CTA) remains unclear. This study investigated whether inhibition of osteoclasts using an anti-receptor activator of nuclear factor κB ligand (RANKL) antibody can suppress joint degeneration in a mouse CTA model without affecting synovial inflammation. Methods: A modified CTA (mCTA) model was established in mice by resecting the supraspinatus and infraspinatus tendons, the superior joint capsule, and the long head of the biceps tendon in the right shoulder of C57BL/6J mice. Mice were assigned to four groups: sham or mCTA, each treated with phosphate-buffered saline or anti-RANKL antibody (5 mg/kg subcutaneously every two weeks). Four weeks post-surgery, histological analyses of the humeral head were performed using the Murine Shoulder Arthritis Score (MSAS), immunohistochemistry for osteoclasts, osteoblasts, RANKL/osteoprotegerin (OPG), inflammatory cytokines, and catabolic enzymes, and quantification of synovial M1 macrophages. Subchondral bone volume (BV) was assessed via the bone volume/tissue volume ratio. Results: The mouse mCTA model reproduced clinically relevant CTA phenotypes, including cartilage degeneration, subchondral bone loss, and joint surface collapse, within four weeks. RANKL expression and osteoclast surface increased in the superior and middle zones, while osteoblasts decreased. Synovial RANKL expression was low and unchanged after mCTA surgery. Anti-RANKL antibody administration significantly suppressed osteoclast surface and preserved subchondral BV, leading to attenuation of cartilage degeneration and reduced expression of inflammatory cytokines and catabolic enzymes in cartilage and subchondral bone. The synovitis score, synovial M1 macrophages, and inflammatory factors were unaffected, indicating that suppression of osteoclasts was sufficient to mitigate joint degeneration. Conclusion: Inhibition of subchondral osteoclasts via anti-RANKL antibody reduces CTA-associated cartilage and bone degeneration without altering synovitis. These findings suggest that targeting osteoclasts may represent a promising disease-modifying strategy for CTA, and targeting RANKL with denosumab may prevent or slow shoulder OA progression. Cite this article: Bone Joint Res 2026;15(10):1183–1195.
- Open Access
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Outcome Analysis in Metastatic Spinal Tumor Surgery Using Minimal Clinically Important Difference
Study Design: Multicenter prospective registry study. Objective: To classify patients according to whether they achieved the minimum clinically important difference (MCID) in health-related quality of life (HRQoL) after surgery for metastatic spinal tumors and to identify preoperative factors associated with clinically meaningful improvement. Summary of Background Data: As survival in patients with metastatic spinal tumors continues to improve, evaluating clinically meaningful changes in HRQoL has become increasingly important. However, factors associated with achieving clinically meaningful postoperative improvement remain unclear. Methods: Between 2018 and 2021, 413 patients undergoing surgery for metastatic spinal tumors were prospectively enrolled from 35 centers in Japan. Patients with available preoperative and 6-month postoperative EQ-5D-5L data were included in the MCID analysis (n=171). Patients were classified into the MCID improvement and non-MCID improvement groups according to the previously established MCID threshold for the EQ-5D-5L index. Patient-reported outcomes (PROs), clinical characteristics, and functional measures were compared between groups, and multivariable logistic regression analysis was performed to identify preoperative factors associated with clinically meaningful improvement. Results: Patients in the MCID improvement group demonstrated significantly greater improvements in the EQ-5D-5L index, EQ-VAS, and other PRO measures than those in the non-MCID improvement group. Compared with the non-MCID improvement group, they had poorer baseline HRQoL, poorer functional status, greater pain, and lower independence in activities of daily living. Exploratory multivariable analysis identified lower independence in dressing and greater impairment in the mobility, pain/discomfort, and anxiety/depression domains as candidate factors associated with clinically meaningful improvement. Conclusion: Patients with poorer baseline HRQoL and functional status were more likely to achieve clinically meaningful improvement after surgery for metastatic spinal tumors. These findings suggest that baseline HRQoL should be considered when interpreting postoperative outcomes and counseling patients regarding the expected benefits of surgical treatment.
- 23 September 2026
- Published by Wolters Kluwer Health in Spine Open
- Vol. 2 (4)
Open AccessOutcome Analysis in Metastatic Spinal Tumor Surgery Using Minimal Clinically Important Difference
Study Design: Multicenter prospective registry study. Objective: To classify patients according to whether they achieved the minimum clinically important difference (MCID) in health-related quality of life (HRQoL) after surgery for metastatic spinal tumors and to identify preoperative factors associated with clinically meaningful improvement. Summary of Background Data: As survival in patients with metastatic spinal tumors continues to improve, evaluating clinically meaningful changes in HRQoL has become increasingly important. However, factors associated with achieving clinically meaningful postoperative improvement remain unclear. Methods: Between 2018 and 2021, 413 patients undergoing surgery for metastatic spinal tumors were prospectively enrolled from 35 centers in Japan. Patients with available preoperative and 6-month postoperative EQ-5D-5L data were included in the MCID analysis (n=171). Patients were classified into the MCID improvement and non-MCID improvement groups according to the previously established MCID threshold for the EQ-5D-5L index. Patient-reported outcomes (PROs), clinical characteristics, and functional measures were compared between groups, and multivariable logistic regression analysis was performed to identify preoperative factors associated with clinically meaningful improvement. Results: Patients in the MCID improvement group demonstrated significantly greater improvements in the EQ-5D-5L index, EQ-VAS, and other PRO measures than those in the non-MCID improvement group. Compared with the non-MCID improvement group, they had poorer baseline HRQoL, poorer functional status, greater pain, and lower independence in activities of daily living. Exploratory multivariable analysis identified lower independence in dressing and greater impairment in the mobility, pain/discomfort, and anxiety/depression domains as candidate factors associated with clinically meaningful improvement. Conclusion: Patients with poorer baseline HRQoL and functional status were more likely to achieve clinically meaningful improvement after surgery for metastatic spinal tumors. These findings suggest that baseline HRQoL should be considered when interpreting postoperative outcomes and counseling patients regarding the expected benefits of surgical treatment.
- 26 August 2026
- Published by Wolters Kluwer Health in Spine
Deep Learning Versus LASSO-Based Machine Learning for 1-Year Survival After Surgery for Spinal Metastases
Study Design.: Multicenter prospective cohort study; secondary analysis. Objective.: To evaluate predictors associated with 1-year survival after surgery for spinal metastases by comparing a comprehensive 50-variable deep learning (DL) model with a previously published 5-variable LASSO-based machine learning (ML) model and applying DL-based permutation feature importance as an exploratory analytic lens. Summary of Background Data.: Surgical decision-making for spinal metastases requires reliable survival estimates. Traditional scores such as those of Tokuhashi and Tomita and contemporary tools such as SORG and NESMS support prognostication, but performance and calibration may vary across cohorts. A parsimonious 5-variable JASA ML model is clinically practical, whereas DL may help identify prognostic signals embedded in detailed activities of daily living (ADLs), patient-reported outcomes (PROs), and scoring-system components. Methods.: We analyzed 401 complete-case patients who underwent surgery for spinal metastases at 35 Japanese institutions (2018-2021). A feed-forward neural network incorporating 50 preoperative variables was evaluated using five repeated random 8:2 train-test splits. Accuracy, AUROC, Brier score, and calibration summaries were reported and descriptively compared with the previously published 5-variable LASSO-based ML model. Results.: At 1 year, 269 of 401 patients were alive. The DL model achieved 75.5+/- 3.0% accuracy (95% confidence interval [CI], 71.8%-79.2%), held-out AUROC 0.789 (95% CI, 0.681-0.886), and Brier score 0.214. The ML model achieved 71.8% accuracy (Wilson 95% CI, 67.2%-76.0%) and apparent AUROC 0.762. Because the comparison was descriptive rather than paired, formal statistical superiority was not claimed. DL feature importance highlighted Vitality Index-On and Off Toilet, EQ-5D-5L total score and pain/discomfort, and individual Tokuhashi/Tomita components; the ML-selected Vitality Index-Wake Up item ranked 38th. Conclusions.: The 50-variable DL model provided reasonable prediction and generated clinically plausible feature-importance hypotheses, but it did not demonstrate a clearly meaningful performance advantage over the simpler 5-variable ML model. DL may be most useful for research-based feature discovery and refinement of future parsimonious prognostic tools, whereas validated simple models remain more practical for bedside prognostication. Level of Evidence.: 2
- 26 August 2026
- Published by Wolters Kluwer Health in Spine
Deep Learning Versus LASSO-Based Machine Learning for 1-Year Survival After Surgery for Spinal Metastases
Study Design.: Multicenter prospective cohort study; secondary analysis. Objective.: To evaluate predictors associated with 1-year survival after surgery for spinal metastases by comparing a comprehensive 50-variable deep learning (DL) model with a previously published 5-variable LASSO-based machine learning (ML) model and applying DL-based permutation feature importance as an exploratory analytic lens. Summary of Background Data.: Surgical decision-making for spinal metastases requires reliable survival estimates. Traditional scores such as those of Tokuhashi and Tomita and contemporary tools such as SORG and NESMS support prognostication, but performance and calibration may vary across cohorts. A parsimonious 5-variable JASA ML model is clinically practical, whereas DL may help identify prognostic signals embedded in detailed activities of daily living (ADLs), patient-reported outcomes (PROs), and scoring-system components. Methods.: We analyzed 401 complete-case patients who underwent surgery for spinal metastases at 35 Japanese institutions (2018-2021). A feed-forward neural network incorporating 50 preoperative variables was evaluated using five repeated random 8:2 train-test splits. Accuracy, AUROC, Brier score, and calibration summaries were reported and descriptively compared with the previously published 5-variable LASSO-based ML model. Results.: At 1 year, 269 of 401 patients were alive. The DL model achieved 75.5+/- 3.0% accuracy (95% confidence interval [CI], 71.8%-79.2%), held-out AUROC 0.789 (95% CI, 0.681-0.886), and Brier score 0.214. The ML model achieved 71.8% accuracy (Wilson 95% CI, 67.2%-76.0%) and apparent AUROC 0.762. Because the comparison was descriptive rather than paired, formal statistical superiority was not claimed. DL feature importance highlighted Vitality Index-On and Off Toilet, EQ-5D-5L total score and pain/discomfort, and individual Tokuhashi/Tomita components; the ML-selected Vitality Index-Wake Up item ranked 38th. Conclusions.: The 50-variable DL model provided reasonable prediction and generated clinically plausible feature-importance hypotheses, but it did not demonstrate a clearly meaningful performance advantage over the simpler 5-variable ML model. DL may be most useful for research-based feature discovery and refinement of future parsimonious prognostic tools, whereas validated simple models remain more practical for bedside prognostication. Level of Evidence.: 2
- Open Access
- 27 July 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1)
Carbon fiber traction table use is associated with a lower incidence of stress shielding and cortical hypertrophy after total hip arthroplasty: a case-control study
The carbon fiber traction table is a specialized platform designed for direct anterior approach (DAA) total hip arthroplasty (THA), providing independent l
- 27 July 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 27 (1)
Open AccessCarbon fiber traction table use is associated with a lower incidence of stress shielding and cortical hypertrophy after total hip arthroplasty: a case-control study
The carbon fiber traction table is a specialized platform designed for direct anterior approach (DAA) total hip arthroplasty (THA), providing independent l
- 21 July 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (20) , E538-E539
Response to Letter to the Editor Regarding “Risk Factors for Early 3-Month Postoperative Mortality in Metastatic Spinal Tumor Surgery: A JASA Multicenter Prospective Study”
Was not provided for this article.
- 21 July 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (20) , E538-E539
Response to Letter to the Editor Regarding “Risk Factors for Early 3-Month Postoperative Mortality in Metastatic Spinal Tumor Surgery: A JASA Multicenter Prospective Study”
Was not provided for this article.
- 10 July 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (19) , E510-E512
Response to the Letter to the Editor Regarding “Predicting Postoperative Neurological Outcomes in Metastatic Spinal Tumor Surgery Using Machine Learning”
Was not provided for this article.
- 10 July 2026
- Published by Wolters Kluwer Health in Spine
- Vol. 51 (19) , E510-E512
Response to the Letter to the Editor Regarding “Predicting Postoperative Neurological Outcomes in Metastatic Spinal Tumor Surgery Using Machine Learning”
Was not provided for this article.
- Open Access
- 9 July 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
Extent of intramedullary short tau inversion recovery signal change predicts traumatic cervical spinal cord injury outcomes in surgically treated older adults: a multicenter study in Japan
A retrospective multicenter study. To determine whether the extent of intramedullary hyperintensity on initi... Asian Spine Journal 2026;():-.
- 9 July 2026
- Published by Asian Spine Journal (ASJ) in Asian Spine Journal
Open AccessExtent of intramedullary short tau inversion recovery signal change predicts traumatic cervical spinal cord injury outcomes in surgically treated older adults: a multicenter study in Japan
A retrospective multicenter study. To determine whether the extent of intramedullary hyperintensity on initi... Asian Spine Journal 2026;():-.
- Open Access
- 4 June 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (12) , 2946-2960
Stepwise loss of shoulder stabilizers induces humeral head migration and progression of cuff tear arthropathy in a rat model
- 4 June 2026
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 35 (12) , 2946-2960
Open AccessStepwise loss of shoulder stabilizers induces humeral head migration and progression of cuff tear arthropathy in a rat model
- Open Access
- 16 March 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 51
Reduced walking speed at discharge predicts mortality after clinical osteoporotic vertebral fracture: A retrospective cohort study
Summary: This study investigated how walking speed affects survival in patients with clinical osteoporotic vertebral fractures. A walking speed below 0.71 m/sec was associated with increased mortality. Walking speed may serve as a simple yet powerful prognostic indicator, highlighting the importance of mobility preservation in fracture management. Purpose: The number of patients with fractures caused by osteoporosis has increased with the increasing proportion of aging adults in recent years. Osteoporotic vertebral fractures (OVFs) are associated with poor prognosis. Although several reports on the life expectancy of patients with OVFs exist, it is unclear how walking speed affects the life expectancy of patients with clinical OVFs. This study investigated the relationship between walking speed and life expectancy after injury in patients with clinical OVFs. Methods: A total of 104 patients with new clinical OVFs were conservatively treated with a trunk cast from 2015 to 2017. Lumbar spine and femur bone mineral density (BMD), the Geriatric Nutritional Risk Index (GNRI), walking speed, and spinopelvic parameters were measured. We compared the deceased and survival groups and examined the risk factors influencing survival. Results: Among the 104 patients included in the study, 67 were women; the median age was 82 years, and the median observation period was 1168 days. Thirty-two patients died during the observation period. The deceased group had a lower GNRI and a slower walking speed at discharge. In addition, imaging revealed more local kyphosis and more calcification of vessels in the deceased group. The risk of death increased when the walking speed after the OVF was less than 0.71 m/sec. Conclusion: A walking speed of 0.71 m/sec or slower was associated with poor prognosis after clinical vertebral fracture. Nutritional management, kyphotic deformity prevention, and walking speed maintenance are essential for vertebral fracture treatment.
- 16 March 2026
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 21 (1) , 51
Open AccessReduced walking speed at discharge predicts mortality after clinical osteoporotic vertebral fracture: A retrospective cohort study
Summary: This study investigated how walking speed affects survival in patients with clinical osteoporotic vertebral fractures. A walking speed below 0.71 m/sec was associated with increased mortality. Walking speed may serve as a simple yet powerful prognostic indicator, highlighting the importance of mobility preservation in fracture management. Purpose: The number of patients with fractures caused by osteoporosis has increased with the increasing proportion of aging adults in recent years. Osteoporotic vertebral fractures (OVFs) are associated with poor prognosis. Although several reports on the life expectancy of patients with OVFs exist, it is unclear how walking speed affects the life expectancy of patients with clinical OVFs. This study investigated the relationship between walking speed and life expectancy after injury in patients with clinical OVFs. Methods: A total of 104 patients with new clinical OVFs were conservatively treated with a trunk cast from 2015 to 2017. Lumbar spine and femur bone mineral density (BMD), the Geriatric Nutritional Risk Index (GNRI), walking speed, and spinopelvic parameters were measured. We compared the deceased and survival groups and examined the risk factors influencing survival. Results: Among the 104 patients included in the study, 67 were women; the median age was 82 years, and the median observation period was 1168 days. Thirty-two patients died during the observation period. The deceased group had a lower GNRI and a slower walking speed at discharge. In addition, imaging revealed more local kyphosis and more calcification of vessels in the deceased group. The risk of death increased when the walking speed after the OVF was less than 0.71 m/sec. Conclusion: A walking speed of 0.71 m/sec or slower was associated with poor prognosis after clinical vertebral fracture. Nutritional management, kyphotic deformity prevention, and walking speed maintenance are essential for vertebral fracture treatment.